AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Mar 27, 2024
35599_dirs_2024-03-27_b7a03d8a-febd-4f54-8efd-dc0881a80176.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-03-26
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-26 | Common Shares | S | 2114 | $10.97 | Disposed | 40920 | Direct |
| 2024-03-26 | Common Shares | M | 4329 | $2.31 | Acquired | 45249 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | Common Shares | $2.31 | M | 4329 | Disposed | 2024-04-25 | Options (4239) | Direct |
Footnotes
F1: Shares sold to satisfy tax obligation on option exercise.
F2: Shares acquired through the exercise of an option pusuant to a 10b5-1 plan adopted on August 17, 2023.
F3: Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20